Instytut Hematologii I Transfuzjologii

2 trials 1 recruiting Academic / non-commercial

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

0 Completed trials

1 Countries active

9 Unique IMPs

N/A Results reported

Phase II

Phase I (Other)

Phase II: 1 Phase I (Other): 1

Top indications

B-cell unclassifiable lymphoma high grade 1 Diffuse large B-cell lymphoma stage II 1 High-grade B-cell lymphoma 1 Diffuse large B-cell lymphoma stage I 1 Diffuse large B-cell lymphoma recurrent 1 Diffuse large B-cell lymphoma stage IV 1 Diffuse large B-cell lymphoma 1 Diffuse large B-cell lymphoma stage III 1

Top IMPs

AXICABTAGENE CILOLEUCEL 1 BENDAMUSTINE HYDROCHLORIDE 1 CISPLATIN 1 CYTARABINE 1 DEXAMETHASONE 1 LENALIDOMIDE 1 POLATUZUMAB VEDOTIN 1 RITUXIMAB 1 TAFASITAMAB 1

All trials

2 total

A phase II efficacy and safety study of cell-free circulating tumor DNA-guided commencement of second-line treatment in patients with DLBCL/… Pending

2024-518275-64-00 Phase II 1 country AXICABTAGENE CILOLEUCEL; BENDAMUSTINE HYDROCHLORIDE; CISPLATIN; CYTARABINE; DEXA…
Phase 1 trial of trametinib and gilteritinib for the treatment of relapsed or refractory acute leukemia patients Recruiting

2024-518301-18-00 Phase I (Other) 1 country

Showing 1–2 of 2 trials

← All sponsors A–Z